Patient with generalized melanoma treated with nivolumab with long-term response after previous failure of combined chemotherapy


MUDr. Taťána Šuková

Dermatovenerologická klinika VFN a 1. LF UK, Praha



Treatment of advances malignant melanoma has seen significant changes in recent years. After decades of stagnation when chemotherapy was used to treat metastatic melanoma the efficacy of which is limited in this tumor, two new drug regimens are now available - advanced imunotherapy offer the chance of long-term survival of nearly 30% of patients.


Key words

melanoma, modern imunotherapy, nivolumab



The full article is only available to subscribers

Become a regular subscriber to our Oncological Review...